Impact of a family-centered discharge and follow up programme on survival, growth, and development of high-risk newborns discharged from a neonatal unit in Kiwoko, Central Uganda

Not Applicable

Completed

• Conditions: High-risk newborns; Neonatal Diseases

• Registration Number: ISRCTN51636372
• Lead Sponsor: Adara Development

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33653756/ (added 14/10/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-09
• Study Completion: 2021-02-15
• Last Update Posted: 24 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 191

Inclusion Criteria

1. Growth, neurodevelopmental assessment and caregiver-child bonding:
1.1. Born in a three-month window (July -Sept 2018 for historical comparison cohort and July-Sept 2020 for intervention cohort)
1.2. Discharged alive from the KH neonatal unit
1.3. 6 months adjusted age at time of assessment (infant may be one week younger or two weeks older than 6 months adjusted age at time of assessment)
1.4. Gestational age available
1.5. Living in 3 surrounding districts (Luweero, Nakaseke, Nakasongola)
1.6. Obtained informed written consent by guardian
2. Parents/caregiver interviews before H2H implementation: those parents/caregivers who will not receive the intervention and are a part of the historical control
3. Parents/caregiver interviews during/after H2H implementation: those parents/caregivers who have received the intervention and are part of the intervention group
4. Clinicians/nurses: those working in Kiwoko Neonatal Intensive Care Unit who have provided written consent
5. Village Health Teams: those who received Adara VHT training and are mobilized for H2H project and who have provided written consent

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified